Published by Iain Gilbert on 14th June 2022
(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Tuesday that the US Food and Drug Administration had notified Homology Medicines that the clinical hold on its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria had been lifted.
URL: http://www.digitallook.com/dl/news/story/32746900/...